Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Dec;12(6):1450–1456. doi: 10.1128/iai.12.6.1450-1456.1975

Comparison of the rate of absorption and proteolysis of [14C]choleragen and [14C]bovine serum albumin in the rat jejunum.

D R Strombeck, D Harrold
PMCID: PMC415454  PMID: 1205622

Abstract

[14C]choleragen was used to study the rate of disappearance of choleragen enterotoxin from the jejunum of rats. [14C]bovine serum albumin (BSA) was studied in a similar manner. Almost one-third of the labeled toxin had disappeared from the intestine after 6 h. Its rate of disappearance was the same in germfree rats as in conventional rats. The rate of proteolysis of [14C]choleragen and [14C]BSA by intestinal mucodal lysosomal enzymes was also studied. Neither was significantly degraded by neutral proteases; however, heat-inactivated toxin was. They were all degraded by acid proteases; however, the rate of BSA proteolysis was only one-third of that of toxin. Soybean trypsin inhibitor had no effect on the in vivo disappearance of toxin nor on the acid proteases. It did inhibit the neutral protease digestion of heat-treated toxin. Aprotinin and protamine inhibited disappearance in loops of gut but had no effect to inhibit degradation rates. Gangliosides inhibited both rates of disappearance and proolysis of toxin. These agents had some different effects on disappearance rates and proteolysis of BSA. The data indicate that cholera enterotoxin is absorbed by intestinal mucosal cells and is degraded by acid proteases in the cells.

Full text

PDF
1450

Images in this article

1454Image
on p.1454
1455Image
on p.1455

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Finkelstein R. A., LaRue M. K., LoSpalluto J. J. Properties of the cholera exo-enterotoxin: effects of dispersing agents and reducing agents in gel filtration and electrophoresis. Infect Immun. 1972 Dec;6(6):934–944. doi: 10.1128/iai.6.6.934-944.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kao V. C., Sprinz H., Burrows W. Localization of cholera toxin in rabbit intestine. An immunohistochemical study. Lab Invest. 1972 Feb;26(2):148–153. [PubMed] [Google Scholar]
  3. Kimberg D. V., Field M., Johnson J., Henderson A., Gershon E. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest. 1971 Jun;50(6):1218–1230. doi: 10.1172/JCI106599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lönnroth I., Holmgren J. Chemical modification of cholera toxin for characterization of antigenic, receptor-binding and toxic sites. FEBS Lett. 1974 Aug 30;44(3):282–285. [PubMed] [Google Scholar]
  5. Misaka E., Tappel A. L. Inhibition studies of cathepsins A, B, C and D from rat liver lysosomes. Comp Biochem Physiol B. 1971 Apr 15;38(4):651–662. doi: 10.1016/0305-0491(71)90268-9. [DOI] [PubMed] [Google Scholar]
  6. Parkinson D. K., Ebel H., DiBona D. R., Sharp G. W. Localization of the action of cholera toxin on adenyl cyclase in mucosal epithelial cells of rabbit intestine. J Clin Invest. 1972 Sep;51(9):2292–2298. doi: 10.1172/JCI107039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Peterson J. W., LoSpalluto J. J., Finkelstein R. A. Localization of cholera toxin in vivo. J Infect Dis. 1972 Dec;126(6):617–628. doi: 10.1093/infdis/126.6.617. [DOI] [PubMed] [Google Scholar]
  8. Pierce N. F., Greenough W. B., 3rd, Carpenter C. C., Jr Vibrio cholerae enterotoxin and its mode of action. Bacteriol Rev. 1971 Mar;35(1):1–13. doi: 10.1128/br.35.1.1-13.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pierce N. F., Reynolds H. Y. Immunity to experimental cholera. II. Secretory and humoral antitoxin response to local and systemic toxoid administration. J Infect Dis. 1975 Apr;131(4):383–389. doi: 10.1093/infdis/131.4.383. [DOI] [PubMed] [Google Scholar]
  10. Schafer D. E., Lust W. D., Sircar B., Goldberg N. D. Elevated concentration of adenosine 3':5'-cyclic monophosphate in intestinal mucosa after treatment with cholera toxin. Proc Natl Acad Sci U S A. 1970 Oct;67(2):851–856. doi: 10.1073/pnas.67.2.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Segal H. I., Winkler J. R., Miyagi M. P. Relationship between digradation rates of proteins in vivo and their susceptibility to lysosomal proteases. J Biol Chem. 1974 Oct 10;249(19):6364–6365. [PubMed] [Google Scholar]
  12. Sharp G. W., Hynie S. Stimulation of intestinal adenyl cyclase by cholera toxin. Nature. 1971 Jan 22;229(5282):266–269. doi: 10.1038/229266a0. [DOI] [PubMed] [Google Scholar]
  13. Strombeck D. R., Harrold D. Binding of cholera toxin to mucins and inhibition by gastric mucin. Infect Immun. 1974 Dec;10(6):1266–1272. doi: 10.1128/iai.10.6.1266-1272.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tennant B., Reina-Guerra M., Harrold D., Goldman M. Influence of microorganisms on intestinal absorption: oleic acid 131-I and triolein 131-I absorption by germfree and conventionalized rats. J Nutr. 1969 Jan;97(1):65–69. doi: 10.1093/jn/97.1.65. [DOI] [PubMed] [Google Scholar]
  15. Walker W. A., Field M., Isselbacher K. J. Specific binding of cholera toxin to isolated intestinal microvillous membranes. Proc Natl Acad Sci U S A. 1974 Feb;71(2):320–324. doi: 10.1073/pnas.71.2.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES